Dear Research Advocate, What do sequencing and sequestration have in common, besides being mysterious words to most people? It’€™s pretty simple: We won’€™t have more of the former if the latter takes place. Why isn’€™t it a Sputnik moment to learn that there is more sequencing capacity at Beijing Genome Institute than we have total capacity in our country? And, to learn that the Chinese government is subsidizing the cost of sequencing so that it is fast becoming the go-to place for industry and academia worldwide? It’€™s time for advocates to talk this up so that policy makers will once again plus-up research as a U.S. priority. Jeffrey Zients, the Acting Director of the White House Office...

Sidebar Quote

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America